E2F7 and non-small cell lung carcinoma: Specifically, the Circ-AASDH/miR-140-3p/E2F7 regulatory axis plays a crucial role in advancing LUAD, while the progression of NSCLC is effectively hindered by celastrol through its action on the circ_SATB2/miR-33a-5p/E2F7 signaling pathway.